US$ 22.47
glp-1 not working compounded glp 1 not working for you? It might not be the Why I'm Choosing Not to
Description
Tirzepatide (Mounjaro) is a once-weekly GLP-1/GIP medication that may help eligible patients manage appetite, support weight loss, and improve long-term weight management under medical supervision

Patients should eat smaller, more frequent meals rather than large portions, avoid high-fat and greasy foods that delay gastric emptying further, and stay well-hydrated throughout the day

For shoppers comparing trusted brands, the list above covers a strong mix of official brands, diabetes resource listings, and marketplace options.
Mounjaro is FDA-approved to treat type 2 diabetes alongside diet and exercise
However, their legacy PBM cautioned that such restrictions might jeopardize their eligibility for rebates, highlighting the complex interplay between cost management and pharmaceutical pricing strategies
